1-6 of 6
Mira Jung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition

Satish Kumar R. Noonepalle, Scott Grindrod, Nima Aghdam, Xintang Li, Maria Gracia-Hernandez, Christian Zevallos-Delgado, Mira Jung, Alejandro Villagra, Anatoly Dritschilo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12): 1376–1389.
https://doi.org/10.1158/1535-7163.MCT-23-0215
Published: 01 December 2023
View article titled, Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition
Open the PDF for Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition in another window
Includes: Supplementary data
Journal Articles

Abstract A178: Targeting the ATM-mediated DNA damage response pathway for cancer treatment

Scott Grindrod, Alfredo Velena, Mira Jung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A178.
https://doi.org/10.1158/1535-7163.TARG-17-A178
Published: 01 January 2018
View article titled, Abstract A178: Targeting the ATM-mediated DNA damage response pathway for cancer treatment
Journal Articles

Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor

Yali Kong, Mira Jung, Kan Wang, Scott Grindrod, Alfredo Velena, Sung A. Lee, Sivanesan Dakshanamurthy, Yonghong Yang, Matthew Miessau, Chaoyi Zheng, Anatoly Dritschilo, Milton L. Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (9): 1591–1599.
https://doi.org/10.1158/1535-7163.MCT-10-0779
Published: 07 September 2011
View article titled, Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
Open the PDF for Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors

Zacharoula Konsoula, Hong Cao, Alfredo Velena, Mira Jung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2844–2851.
https://doi.org/10.1158/1535-7163.MCT-09-0629
Published: 12 October 2009
View article titled, Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors
Open the PDF for Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors in another window
Includes: Supplementary data
Journal Articles

Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds

Mira Jung, Yin Zhang, Alexandre Dimtchev, Manny R. Subramanian, Krishman Suthanthiran, Anatoly Dritschilo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (6): 655–659.
https://doi.org/10.1158/1535-7163.655.3.6
Published: 21 June 2004
View article titled, Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds
Open the PDF for Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds in another window
Journal Articles

The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells

Kyoung M. Kim, Yin Zhang, Bo-Yeon Kim, Sook J. Jeong, Sung A. Lee, Gun-Do Kim, Anatoly Dritschilo, Mira Jung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (6): 693–698.
https://doi.org/10.1158/1535-7163.693.3.6
Published: 21 June 2004
View article titled, The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells
Open the PDF for The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells in another window